An independent research and harm-reduction resource

We review published research on performance-enhancing drugs and related research chemicals, and translate it into something a non-specialist can actually use. Each analysis states the compound, what the human literature shows, how strong that evidence is, and what remains unknown. Community experience is included where it is informative, but it is always presented separately from published research and labelled as anecdotal.

We also assess the Australian vendors people are already buying from, because transparency about who is selling matters as much as the pharmacology. Those assessments use one published set of metrics, applied identically to everyone.

We do not sell, supply, source or promote the use of any substance. We do not publish dosing protocols, cycles or instructions for use. We take no payment from vendors in any form — no advertising, no affiliate links, no paid placement, no sponsored analyses — and no vendor has any input into what we publish about them.

We do not give individual medical advice. Nothing on this site substitutes for assessment by a qualified clinician who knows your history.

APEDRA is a self-funded editorial project. There is no commercial relationship with any vendor, laboratory, supplement brand or clinic named anywhere on this site. That is the single most important thing to know when reading a vendor comparison — most "best supplier" content in this market is affiliate-driven, and the ranking follows the commission.

If that ever changes, it will be disclosed on this page before it appears anywhere else.

People using these compounds are often already using them, frequently without bloodwork, clinical oversight or accurate information about what is in the vial. Telling that audience only "don't" reliably fails: it pushes them toward forums and sellers instead. Explaining what the evidence shows, what is genuinely unknown, which warning signs matter and when to see a doctor is a better use of a research team.

That is a reason for clarity, not a recommendation. Several compounds we cover have no completed human safety programme at all, and we say so directly in each analysis.